BRITISH ASSOCIATION FOR CANCER RESEARCH
TRUSTEES' REPORT FOR THE YEAR ENDED 31[ST] MARCH 2024
Reference and Administrative Details of the Charity, its Trustees and Advisors
There are three officers of the Association: The Chairman, The Honorary Secretary and The Honorary Treasurer. The Chairman is an ordinary member who is elected to office annually for a maximum threeyear term by the ordinary members at an Annual General Meeting; The Honorary Secretary and Honorary Treasurer are both ordinary members, elected by the ordinary members present at the Annual General Meeting; both serve until the next Annual General Meeting and are eligible for re-election up to a maximum term of five years. There is a one-year overlap between the final year of the current officer’s term of office, and the first year of the newly appointed officer (termed officer-elect for this period). This overlap period facilitates smooth transition between officer posts and their successors. The Association's Executive Committee consists of the three Officers of the Association (plus any officer-elects), plus nine ordinary members elected as described in the Rules. Provision is also made to co-opt member(s) where specific expertise is required. The President holds a non-executive position, is not a trustee and is elected for a four-year term.
For the accounting period the BACR Executive comprised of: Professor Adrian L Harris (President), Professor Ingunn Holen (Chair), Professor Charlotte Bevan (Honorary Secretary), Professor Joanne Edwards (Honorary Treasurer), William Brackenbrugy, Tim Fenton, Anita Grigoriadis, Jack Leslie, John Marshall, Alan McIntyre, Munitta Muthana, George Poulogiannis, Stephen Tait and Anna Wilkins.
Newly elected trustees are supplied with documentation, obtained from the Charity Commission, outlining their responsibilities as trustees of the Charity. They, along with pre-existing trustees, are also regularly updated with Charity Commission News. The association is also a member of the National Council of Voluntary Organisations (NCVO) that keeps it informed of relevant voluntary sector and charity information.
Structure, Governance and Management
The Association is constituted as an unincorporated association, and its governing document is its constitution. The BACR has a charitable registration number (289297) and its principal address during this reporting period was BACR Secretariat, c/o Leeds Institute of Medical Research, at, St. James’s Cancer Genetics Building, St James’s University Hospital, Beckett Street, Leeds, LS9 7TF.
The Association maintains its own Secretariat: Mrs Janet Alexander (based within the Leeds Institute of Medical Research at St James) who was appointed as the BACR Administrative Secretary on 1[st] January 2010.
Applicable law requires the trustees to prepare for each financial year accounts that give a true and fair view of the state of affairs of the Association and the surplus or deficit of the Association for that period. In preparing those accounts the Trustees are required to:
-
select suitable accounting policies and then apply them consistently
-
make judgements and estimates which are reasonable
-
prepare the accounts on a going-concern basis unless it is inappropriate to presume that the Association will continue in business
The trustees are responsible for keeping proper accounting records, which disclose with reasonable accuracy at any time the financial position of the Association and to enable them to ensure that the accounts comply with the Charities Act, 2011. They are also responsible for safeguarding the assets of the Association and hence for taking reasonable steps for the prevention of and detection of fraud and other irregularities.
The BACR accounts are scrutinized annually by Independent Examiners; their report is appended to this trustees’ report. A resolution to appoint Independent Examiners ahead of the next financial year will be put forward to the membership by the Honorary Treasurer, at the 2023 AGM.
1
Objectives and Activities
Under its Constitution, the Association's objects are for the promotion of the advance of research in relation to all aspects of cancer by encouraging the exchange of information. The policies adopted in furtherance of these are (i) the organising of meetings and workshops and (ii) the provision of funds to support BACR members in attending these and other such meetings. There has been no change in the remit of the BACR with respect to its activities during the reporting period with the caveat that the COVID19 pandemic has limited travel opportunities for its members.
Achievements and Performance
During the reporting period the Association held Trailblazers in Cancer Research, the Next Generation for early career researchers. This was in June 2022 at the Pendulum Hotel, Manchester, this was well attended and feedback was overwhelmingly positive with discussion that this may become a regular event every 2 to 3 years. In addition, Tumour Microenvironment and 3D Model Workshop on the 6[th] to 8[th] September 2023 Nottingham Trent University, Nottingham.
The 2023-24 financial year the Association is delighted to announce that 39 awards worth a total of £41,711.73 were made to research students and established cancer researchers to present their work at international scientific conferences and visit overseas laboratories to learn new techniques. Some of these costs will be incurred during 2024-25 with a total of £33,880 being spent in the 2023-24 financial year.
Financial Review
The principal funding source for the association is its capital investment and membership subscriptions. The investment portfolio is managed with an ethical concern that prohibits funds being invested in any tobacco or tobacco-related companies and during the financial year the trustees also agreed that the Association should not invest in companies related to the production of alcohol. The portfolio management company delivers an annual report to trustees with additional advice being delivered, also in the form of an annual report, by an independent financial advisor. The Association does not currently have any social programme related investments. At March 2024, had a market value of £1,110,108.
In the course of its normal activities, the BACR recorded an operating deficit for the year of £63,779.
Plans for the Future
Looking ahead to 2024-25, the Association is hosting Response and Resistance meeting which will be held on the 8[th] to 10[th] July 2024 and New Developments in Breast Cancer Meeting on the 25[th] to 27[th] November 2024.
The BACR 65[th] Annual meeting will be held on the 2[nd] to 4[th] June 2025.
By order of the Executive Committee
Professor Joanne Edwards, Honorary Treasurer, BACR, 30[th] October 2024.
2
BRITISH ASSOCIATION FOR CANCER RESEARCH
Registered Charity No.289297
Accounts for the period 1st April 2023 to 31st March 2024
President
Prof. Adrian Harris
Chair
Prof. Ingunn Holen
Honorary Treasurer
Prof. Joanne Edwards
Honorary Secretary
Prof. Charlotte Bevan
Secretariat
Janet Alexander Leeds Institute of Medical Research at St James's Cancer Genetics Building St James's University Hospital Beckett Street Leeds LS9 7TF
Bankers
National Westminster Bank PLC 501 Silbury Boulevard Saxon Gate East Central Milton Keynes MK9 3ER
Independent Examiners
UHY BPR Heaton Chartered Accountants Glenewes House, Gateway Drive Yeadon LS19 7XY
BRITISH ASSOCIATION FOR CANCER RESEARCH
Contents of the
Accounts for the period 1st April 2023 to 31st March 2024
| Page | |
|---|---|
| Trustees' Report | 1 |
| Independent Examiners' Report | 3 |
| Statement of Financial Activities | 4 |
| Balance Sheet | 5 |
| Notes to the Accounts | 6 |
| Income and Expenditure Account | 9 |
BRITISH ASSOCIATION FOR CANCER RESEARCH
TRUSTEES' REPORT FOR THE YEAR ENDED 31[ST] MARCH 2024
Reference and Administrative Details of the Charity, its Trustees and Advisors
There are three officers of the Association: The Chairman, The Honorary Secretary and The Honorary Treasurer. The Chairman is an ordinary member who is elected to office annually for a maximum threeyear term by the ordinary members at an Annual General Meeting; The Honorary Secretary and Honorary Treasurer are both ordinary members, elected by the ordinary members present at the Annual General Meeting; both serve until the next Annual General Meeting and are eligible for re-election up to a maximum term of five years. There is a one-year overlap between the final year of the current officer’s term of office, and the first year of the newly appointed officer (termed officer-elect for this period). This overlap period facilitates smooth transition between officer posts and their successors. The Association's Executive Committee consists of the three Officers of the Association (plus any officer-elects), plus nine ordinary members elected as described in the Rules. Provision is also made to co-opt member(s) where specific expertise is required. The President holds a non-executive position, is not a trustee and is elected for a four-year term.
For the accounting period the BACR Executive comprised of: Professor Adrian L Harris (President), Professor Ingunn Holen (Chair), Professor Charlotte Bevan (Honorary Secretary), Professor Joanne Edwards (Honorary Treasurer), William Brackenbrugy, Tim Fenton, Anita Grigoriadis, Jack Leslie, John Marshall, Alan McIntyre, Munitta Muthana, George Poulogiannis, Stephen Tait and Anna Wilkins.
Newly elected trustees are supplied with documentation, obtained from the Charity Commission, outlining their responsibilities as trustees of the Charity. They, along with pre-existing trustees, are also regularly updated with Charity Commission News. The association is also a member of the National Council of Voluntary Organisations (NCVO) that keeps it informed of relevant voluntary sector and charity information.
Structure, Governance and Management
The Association is constituted as an unincorporated association, and its governing document is its constitution. The BACR has a charitable registration number (289297) and its principal address during this reporting period was BACR Secretariat, c/o Leeds Institute of Medical Research, at, St. James’s Cancer Genetics Building, St James’s University Hospital, Beckett Street, Leeds, LS9 7TF.
The Association maintains its own Secretariat: Mrs Janet Alexander (based within the Leeds Institute of Medical Research at St James) who was appointed as the BACR Administrative Secretary on 1[st] January 2010.
Applicable law requires the trustees to prepare for each financial year accounts that give a true and fair view of the state of affairs of the Association and the surplus or deficit of the Association for that period. In preparing those accounts the Trustees are required to:
-
select suitable accounting policies and then apply them consistently
-
make judgements and estimates which are reasonable
-
prepare the accounts on a going-concern basis unless it is inappropriate to presume that the Association will continue in business
The trustees are responsible for keeping proper accounting records, which disclose with reasonable accuracy at any time the financial position of the Association and to enable them to ensure that the accounts comply with the Charities Act, 2011. They are also responsible for safeguarding the assets of the Association and hence for taking reasonable steps for the prevention of and detection of fraud and other irregularities.
The BACR accounts are scrutinized annually by Independent Examiners; their report is appended to this trustees’ report. A resolution to appoint Independent Examiners ahead of the next financial year will be put forward to the membership by the Honorary Treasurer, at the 2024 AGM.
1
Objectives and Activities
Under its Constitution, the Association's objects are for the promotion of the advance of research in relation to all aspects of cancer by encouraging the exchange of information. The policies adopted in furtherance of these are (i) the organising of meetings and workshops and (ii) the provision of funds to support BACR members in attending these and other such meetings. There has been no change in the remit of the BACR with respect to its activities during the reporting period.
Achievements and Performance
During the reporting period the Association held Trailblazers in Cancer Research, the Next Generation for early career researchers. This was in June 2022 at the Pendulum Hotel, Manchester, this was well attended and feedback was overwhelmingly positive with discussion that this may become a regular event every 2 to 3 years. In addition, Tumour Microenvironment and 3D Model Workshop on the 6[th] to 8[th] September 2023 Nottingham Trent University, Nottingham.
The 2023-24 financial year the Association is delighted to announce that 39 awards worth a total of £41,712 were made to research students and established cancer researchers to present their work at international scientific conferences and visit overseas laboratories to learn new techniques. Some of these costs will be incurred during 2024-25 with a total of £33,880 being spent in the 2023-24 financial year.
Financial Review
The principal funding source for the association is its capital investment and membership subscriptions. The investment portfolio is managed with an ethical concern that prohibits funds being invested in any tobacco or tobacco-related companies and during the financial year the trustees also agreed that the Association should not invest in companies related to the production of alcohol. The portfolio management company delivers an annual report to trustees with additional advice being delivered, also in the form of an annual report, by an independent financial advisor. The Association does not currently have any social programme related investments. At 31 March 2024, had a market value of £1,104,229.
In the course of its normal activities, the BACR recorded an operating deficit for the year of £63,779.
Plans for the Future
Looking ahead to 2024-25, the Association is hosting Response and Resistance meeting which was held on the 8[th] to 10[th] July 2024 and New Developments in Breast Cancer Meeting is scheduled to be held on the 25[th] to 27[th] November 2024.
The BACR 65[th] Annual meeting will be held on the 2[nd] to 4[th] June 2025.
By order of the Executive Committee
Professor Joanne Edwards, Honorary Treasurer, BACR,
2
INDEPENDENT EXAMINERS REPORT TO THE TRUSTEES OF THE BRITISH ASSOCIATION FOR CANCER RESEARCH (CHARITY NO. 2892971 Independent examln¢r's report to the trustees of tho British Association For Cancer Research I report to the charity trustees on my examination of the accounts of the British Association for Cancer Research Ilhe Irustl for year ended 31 March 2024. Responsibilities and basis of report As the charity trustees ol the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 20111'the Act'l. I report in resp8cl of my examination of the Trust's accounts Carried out under Section 145 of th8 Act and in carrying out my examination I have followed 811 applicable directions given by the charity commission under Section 145(5llbl of the Act. Independent examlnar's statement I have completed my examinalion. I confim that no material matters have come lo my attention in conneclion wlh the axarninalion giving me cause lo believe that in any material respect.. 11 accounting records were nol kept in resp&¢t of the Trust as required by Section 130 of the Act.. or 21 the accounts do not accord with those records., or 31 Ihe accounts do not comply with the applicable requirements conc8ming the form and conlenl of accounts sel out in the Charities (Accounts and Rèports) Reoulalions 2008 other than any rgquiremenl that the accounts give a true and fair view which is not a matter considered as part of an indep8ndent examination. I have no concerns and have come across no oth8r mallers in connection with the examination to which attention should be drawn in this report in order lo enable a proper understanding of the accounts to be reached. Stephen B Hinchcliffe ACA FCCA UHY BPR Healon Chartered Accountsnts Glenewes House Gale Way Drive Leeds Wesl Yorkshire LS19 7XY 28 November 2024
BRITISH ASSOCIATION FOR CANCER RESEARCH
STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31ST MARCH 2024
| Note Incoming resources From generated funds; Voluntary income Activities for generating funds Investment income From charitable activities Total incoming resources Resources expended Costs of generating funds; Costs of generating funds Charitable activities Governance costs 2 Total resources expended Net incoming/(outgoing) resources before transfers Transfers Gross transfers between funds Net incoming/(outgoing) resources before holding gains and losses Transfers between funds Holding gains/(losses)-(realised and unrealised) Gains/(losses) on investment assets 3 Net movements in funds Reconciliation of Funds Total funds brought forward Total funds carried forward |
Restricted Funds £ - - - - |
Unrestricted Funds £ 6,476 70,607 31,543 44,079 |
Total Funds £ 6,476 70,607 31,543 44,079 |
Prior Period Total Funds £ 5,999 84,097 21,112 55,847 |
|---|---|---|---|---|
| - | 152,705 | 152,705 | 167,055 | |
| - 13,856 - |
138,398 61,770 2,460 |
138,398 75,626 2,460 |
124,290 71,896 2,586 |
|
| 13,856 | 202,628 | 216,484 | 198,773 | |
| (13,856) - |
(49,923) - |
(63,779) - |
(31,718) - |
|
| - (13,856) - |
- (49,923) 64,523 |
- (63,779) 64,523 |
- (31,718) (76,981) |
|
| (13,856) 37,366 |
14,600 1,476,870 |
744 1,514,236 |
(108,699) 1,622,935 |
|
| 23,510 | 1,491,470 | 1,514,980 | 1,514,236 |
4
BRITISH ASSOCIATION FOR CANCER RESEARCH
BALANCE SHEET AS AT 31ST MARCH 2024
| Notes FIXED ASSETS 4 Investments Intangible assets Tangible assets CURRENT ASSETS Debtors 5 Cash at bank and in hand 6 CREDITORS Amounts falling due within one year 7 NET CURRENT ASSETS/ (LIABILITIES) TOTAL ASSETS LESS CURRENT LIABILITIES INCOME FUNDS Restricted funds 8 Unrestricted funds |
2024 £ 1,104,029 - - 1,104,029 7,030 448,169 455,199 44,248 410,951 1,514,980 23,510 1,491,470 1,514,980 |
2023 £ 1,039,506 - - |
|---|---|---|
| 1,039,506 | ||
| 4,808 510,422 |
||
| 515,230 40,500 |
||
| 474,730 | ||
| 1,514,236 | ||
| 37,366 1,476,870 |
||
| 1,514,236 |
The accounts were approved by the Honorary Treasurer on behalf of the Executive Committee.
Joanne Edwards - Honorary Treasurer 5 November 2024
5
BRITISH ASSOCIATION FOR CANCER RESEARCH
NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31ST MARCH 2024
1. ACCOUNTING POLICIES
Basis of preparing the financial statements
The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention.
The financial statements are presented in sterling which is the functional currency of the charity rounded to the nearest pound.
Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.
Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.
Taxation
The charity is exempt from tax on its charitable activities.
Fund Accounting
The accounts include the results of the charities operations, which include unrestricted and restricted funds.
Restricted funds
The association has the following restricted fund;
The AstraZeneca Fund, which combines the Tom Connors AstraZeneca Fund with the Frank Rose Fund. This fund provides support for both annual BACR AstraZeneca Young Scientist Frank Rose Award Lecture.
Movements in this fund are detailed in Note 8 to the accounts.
Fixed assets investments
Investments are included at market value.
Tangible fixed assets and depreciation
Fixtures and fittings are written off on a 15% reducing balance basis.
Intangible assets and amortisation
The website development cost has been amortised in full.
Future meetings
Payments made and income received in respect of meetings to be held in a future year are carried forward to be brought into account in the year in which the meetings are held.
Deficit and surpluses on joint meetings
The association makes provision for the receipt, from third party organisers of meetings held during the year, and for payments to third party organisers for the Association's share of any deficits arising on such meetings, only when the sums involved can be accurately quantified, or have been either received or paid, as appropriate.
6
BRITISH ASSOCIATION FOR CANCER RESEARCH
NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31ST MARCH 2024, continued
| 2024 £ 2. SUPPORT COSTS Committee travel expenses Governance - Accountancy Costs 2,460 University of Leeds - Employee costs 82,162 Bank and PayPal charges 973 85,595 3 Investment gains/(losses) Market value carried forward 1,104,029 Funds invested in the year - Market value brought forward (1,039,506) Gain/(loss) for the year 64,523 4. FIXED ASSETS Investments Market Value at 1st April 2023 1,004,987 Acquisitions at cost 100,201 Disposals at cost (97,346) Gains/(losses) in the period 157 Unrealised gains/(losses) in the period 78,017 Market Value at 31st March 2024 1,086,016 Cash holding at 31st March 2024 18,013 1,104,029 Historical cost at 31st March 2024 855,707 The Association's investments are managed by Quilter Cheviot Limited. Intangible Assets - Website Cost at 1st April 2023 and 31st March 2024 20,304 Depreciation at 1st April 2023 and 31st March 2024 20,304 Net Book Value at 31st March 2024 - Tangible Assets Cost at 1st April 2022 - Disposals in year - At 31 March 2023 - Depreciation at 1st April 2023 - Charge for period - Eliminated on disposal - Accumulated depreciation at 31st March 2024 - Net Book Value at 31st March 2024 - Allocation 50% Charitable activities |
2024 £ 2. SUPPORT COSTS Committee travel expenses Governance - Accountancy Costs 2,460 University of Leeds - Employee costs 82,162 Bank and PayPal charges 973 85,595 3 Investment gains/(losses) Market value carried forward 1,104,029 Funds invested in the year - Market value brought forward (1,039,506) Gain/(loss) for the year 64,523 4. FIXED ASSETS Investments Market Value at 1st April 2023 1,004,987 Acquisitions at cost 100,201 Disposals at cost (97,346) Gains/(losses) in the period 157 Unrealised gains/(losses) in the period 78,017 Market Value at 31st March 2024 1,086,016 Cash holding at 31st March 2024 18,013 1,104,029 Historical cost at 31st March 2024 855,707 The Association's investments are managed by Quilter Cheviot Limited. Intangible Assets - Website Cost at 1st April 2023 and 31st March 2024 20,304 Depreciation at 1st April 2023 and 31st March 2024 20,304 Net Book Value at 31st March 2024 - Tangible Assets Cost at 1st April 2022 - Disposals in year - At 31 March 2023 - Depreciation at 1st April 2023 - Charge for period - Eliminated on disposal - Accumulated depreciation at 31st March 2024 - Net Book Value at 31st March 2024 - Allocation 50% Charitable activities |
2023 £ 246 2,340 78,082 703 |
|---|---|---|
| 81,371 | ||
| 1,039,506 (200,000) (916,487) |
||
| (76,981) | ||
| 916,487 351,661 (129,414) 28,238 (161,985) |
||
| 1,004,987 34,519 |
||
| 1,039,506 | ||
| 852,851 | ||
| 20,304 | ||
| 20,304 | ||
| - | ||
| 1,971 (1,971) |
||
| - | ||
| 1,625 (1,625) |
||
| - | ||
| - | - |
7
BRITISH ASSOCIATION FOR CANCER RESEARCH
NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31ST MARCH 2024, continued
| 5. DEBTORS Prepayments and accrued income 6. CASH AT BANK Current account Reserve account Astra - Zeneca Hamilton - Fairley Translational Award 7. CREDITORS: Amounts falling due within one year Creditors and accrued expenditure 8. RESTRICTED FUNDS Balance at 1st April 2023 Awards and costs Balance at 31st March 2024 |
2024 £ 7,030 |
2023 £ 4,808 |
|---|---|---|
| 100 448,069 - - - |
100 493,464 13,602 781 2,475 |
|
| 448,169 | 510,422 | |
| 44,248 | 40,500 | |
| Astra - Zeneca 37,366 (13,856) |
Total 37,366 (13,856) |
|
| 23,510 | 23,510 |
9. RELATED PARTY TRANSACTIONS
The Charity is controlled by it's Trustees.
There have not been any material transactions with any related party during the year.
10. POST BALANCE SHEET EVENTS
The market value of Investments stated in note 4 as at 27 November 2024 was in the sum of £1,139,150 including cash holdings of £26,339.
8
BRITISH ASSOCIATION FOR CANCER RESEARCH
INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31ST MARCH 2024
| Income Voluntary income Donations and Legacies Activities for generating funds Tumour Microenvironment and 3D Model Workshop Trailblazers in Cancer Research Investment income Interest and dividends receivable From charitable activities Subscriptions Astex Therapeutics contribution to Roger Griffin award Astra Zeneca contribution to travel awards Provisions no longer required Total income Expenditure Costs of generating funds BACR conferences Recharged employee costs EACR Membership Printing, postage, stationery, advertising and publications Bank and PayPal charges Loss on disposal of fixed assets Charitable activities Travel awards and bursaries National Council for Volunteer Organisations Recharged employee costs Bank and PayPal charges Loss on disposal of fixed assets Governance costs Committee travel and other expenses Accountancy Surplus/(deficit) for the year |
Restricted Funds £ - - - - - - - - |
Unrestricted Funds £ 6,476 49,946 20,661 31,543 43,532 - - 547 |
Total Funds £ 6,476 49,946 20,661 31,543 43,532 - - 547 152,705 85,515 41,081 7,649 3,666 487 - 33,880 179 41,081 487 - - 2,460 216,484 (63,779) |
Prior Year Total Funds £ 5,999 84,097 - 21,112 50,347 2,000 - 3,500 |
|---|---|---|---|---|
| - | 152,705 | 167,055 | ||
| - - - - - - 13,856 - - - - - - |
85,515 41,081 7,649 3,666 487 - 20,024 179 41,081 487 - - 2,460 |
75,686 39,041 6,391 2,821 352 - 32,329 175 39,041 352 - 246 2,340 |
||
| 13,856 | 202,628 | 198,773 | ||
| (13,856) | (49,923) | (31,718) |
9
INDEPENDENT EXAMINERS REPORT TO THE TRUSTEES OF THE BRITISH ASSOCIATION FOR CANCER RESEARCH (CHARITY NO. 2892971 Independent examln¢r's report to the trustees of tho British Association For Cancer Research I report to the charity trustees on my examination of the accounts of the British Association for Cancer Research Ilhe Irustl for year ended 31 March 2024. Responsibilities and basis of report As the charity trustees ol the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 20111'the Act'l. I report in resp8cl of my examination of the Trust's accounts Carried out under Section 145 of th8 Act and in carrying out my examination I have followed 811 applicable directions given by the charity commission under Section 145(5llbl of the Act. Independent examlnar's statement I have completed my examinalion. I confim that no material matters have come lo my attention in conneclion wlh the axarninalion giving me cause lo believe that in any material respect.. 11 accounting records were nol kept in resp&¢t of the Trust as required by Section 130 of the Act.. or 21 the accounts do not accord with those records., or 31 Ihe accounts do not comply with the applicable requirements conc8ming the form and conlenl of accounts sel out in the Charities (Accounts and Rèports) Reoulalions 2008 other than any rgquiremenl that the accounts give a true and fair view which is not a matter considered as part of an indep8ndent examination. I have no concerns and have come across no oth8r mallers in connection with the examination to which attention should be drawn in this report in order lo enable a proper understanding of the accounts to be reached. Stephen B Hinchcliffe ACA FCCA UHY BPR Healon Chartered Accountsnts Glenewes House Gale Way Drive Leeds Wesl Yorkshire LS19 7XY 28 November 2024